Technology: CAR-T, CAR-T therapy, Cell_Therapies, RNA
Industry: AI, Public
Headquarters: Mainz, Rheinland-Pfalz, Germany
Founded Date: 2008-01-01
Employees Number: 1001-5000
Funding Status: IPO
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: 3
Acquisitions Number: Made Acquisitions
Investors Number: 16
Total Funding: 1141164024
Estimated Revenue: $100M to $500M
Last Funding Date: 2022-04-14
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership